3Hartenbach EM, Saltzman AK, Carter JR, et al. A novel strategy using G-SCF to support EMA/CO for high-rish gestational trophoblastie disease[J]. Gyneeol Oneol, 1995, 56(1):105-108. 被引量：1
8Newlands ES, Bagshawe KD, Begent RH, et al. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol, 1991,98:550-557. 被引量：1
9Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol,2000,18:854-859. 被引量：1
10Randall TC, Coukos G, Wheeler JE, et al. Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy. Gynecol Oncol, 2000, 76:115-117. 被引量：1
